Key Financial Data Of Reporting Company

NANO MRNA Co.,Ltd. - Filing #7296479

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-09-30
2023-04-01 to
2023-09-30
Key financial data of reporting company
Business results of reporting company
Net sales
7,700,000 JPY
135,508,000 JPY
91,108,000 JPY
Ordinary profit (loss)
-382,431,000 JPY
-749,847,000 JPY
-471,447,000 JPY
Net assets
3,057,228,000 JPY
3,421,388,000 JPY
3,791,806,000 JPY
Total assets
4,739,962,000 JPY
5,071,279,000 JPY
5,439,146,000 JPY
Basic earnings (loss) per share
-7.36
-11.10
-6.80
Diluted earnings per share
Equity-to-asset ratio
0.642 xbrli:pure
0.672 xbrli:pure
0.694 xbrli:pure
Net cash provided by (used in) operating activities
-268,192,000 JPY
-585,081,000 JPY
-330,332,000 JPY
Net cash provided by (used in) investing activities
1,601,710,000 JPY
793,007,000 JPY
406,537,000 JPY
Net cash provided by (used in) financing activities
0 JPY
3,728,000 JPY
3,728,000 JPY
Cash and cash equivalents
2,883,581,000 JPY
1,575,263,000 JPY
1,437,326,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.